Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14AZURITY

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8114909

Drug Substance Claim :

Drug Product Claim :

Application Number : 22399

Patent Use Code : U-1231

Delist Requested :

Patent Use Description : TREATMENT OF MODERATE-...

Patent Expiration Date : 2026-04-11

blank

02

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8686034

Drug Substance Claim :

Drug Product Claim :

Application Number : 22399

Patent Use Code : U-1231

Delist Requested :

Patent Use Description : TREATMENT OF MODERATE-...

Patent Expiration Date : 2025-01-24

blank

03

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8686034

Drug Substance Claim :

Drug Product Claim :

Application Number : 22399

Patent Use Code : U-1247

Delist Requested :

Patent Use Description : MANAGEMENT OF POSTHERP...

Patent Expiration Date : 2025-01-24

blank

04

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8795725

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22399

Patent Use Code : U-1231

Delist Requested :

Patent Use Description : TREATMENT OF MODERATE-...

Patent Expiration Date : 2029-06-10

blank

05

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8795725

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22399

Patent Use Code : U-1231

Delist Requested :

Patent Use Description : TREATMENT OF MODERATE-...

Patent Expiration Date : 2029-06-10

blank

06

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8686034

Drug Substance Claim :

Drug Product Claim :

Application Number : 22399

Patent Use Code : U-1247

Delist Requested :

Patent Use Description : MANAGEMENT OF POSTHERP...

Patent Expiration Date : 2025-01-24

blank

07

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8795725

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22399

Patent Use Code : U-1247

Delist Requested :

Patent Use Description : MANAGEMENT OF POSTHERP...

Patent Expiration Date : 2029-06-10

blank

08

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8114909

Drug Substance Claim :

Drug Product Claim :

Application Number : 22399

Patent Use Code : U-1231

Delist Requested :

Patent Use Description : TREATMENT OF MODERATE-...

Patent Expiration Date : 2026-04-11

blank

09

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8686034

Drug Substance Claim :

Drug Product Claim :

Application Number : 22399

Patent Use Code : U-1231

Delist Requested :

Patent Use Description : TREATMENT OF MODERATE-...

Patent Expiration Date : 2025-01-24

blank

10

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

GABAPENTIN ENACARBIL

US Patent Number : 8795725

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22399

Patent Use Code : U-1247

Delist Requested :

Patent Use Description : MANAGEMENT OF POSTHERP...

Patent Expiration Date : 2029-06-10

blank